• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Rx to-otc switching strategies - new switching
 

Rx to-otc switching strategies - new switching

on

  • 208 views

Aarkstore.com 10% Discount || Rx-to-OTC Switching Strategies - New Switching Opportunities ||

Aarkstore.com 10% Discount || Rx-to-OTC Switching Strategies - New Switching Opportunities ||

Statistics

Views

Total Views
208
Views on SlideShare
208
Embed Views
0

Actions

Likes
0
Downloads
3
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Rx to-otc switching strategies - new switching Rx to-otc switching strategies - new switching Document Transcript

    • Aarkstore.com announces, The Latest market research report is available inits vast collection:Rx-to-OTC Switching Strategies - New Switching Opportunitiesin Weight Management and Smoking Cessation, butEncouraging the Uptake of Self-Medication Remains aChallengehttp://www.aarkstore.com/reports/Rx-to-OTC-Switching-Strategies-New-Switching-Opportunities-in-Weight-Management-and-Smoking-Cessation-but-Encouraging-the-Uptake-of-Self-Medication-Remains-a-Challenge-200530.htmlSummaryGBI Research, a leading business intelligence provider, has released its latestresearch “Rx-to-OTC Switching Strategies - New Switching Opportunities in WeightManagement and Smoking Cessation, but Encouraging the Uptake of Self-MedicationRemains a Challenge” examines the key issues influencing the global OTC marketand assesses why companies switch Rx drugs to OTC, their business strategies andthe potential challenges and opportunities this creates. It provides an analysis of theglobal OTC market and forecasts broken down by geography and therapy areas. Itdiscusses the national and international factors which impact the OTC market andcompanies operating in the OTC market. The report reviews the regulatorylandscape in the US, Europe and Japan and highlights recent changes in regulatoryprocedures and guidelines. Therapy profiles provide a detailed analysis of theleading OTC drug classes and Company profiles provide a detailed analysis of theleading OTC companies. Finally the report discusses the challenges and futureopportunities in the OTC market, business strategies and future outlook.Scope- Data and analysis on the Rx-to-OTC switch market in the top seven countries which
    • includes the US, the UK, France, Germany, Spain, Italy and Japan,- Market Data on geographical landscape including country wise revenues, marketsize and market share.- Key drivers and restraints that have created significant impact on the market.- Regulatory landscape including the product approval process and overview ofregulatory authorities in the top seven countries.Table of contents:1 Table of Contents 41.1 List of Tables 61.2 List of Figures 72 Introduction 82.1 What Defines an OTC Product? 82.2 Why do Companies Switch Rx Products OTC? 82.3 Which OTC Products are Currently Available? 82.4 What Geographical Markets Attract OTC Switching? 102.5 What Are the Potential New Areas For OTC Drug Development and Why? 122.6 GBI Research Report Guidance 133 Market Characterization and Forecasts 143.1 Global OTC Market by Revenues 143.2 Global OTC Market by Region 153.3 Global OTC Market - Key Players 163.4 Global OTC Market by Therapy 173.5 The European OTC Market 183.5.1 France 203.5.2 Germany 203.5.3 Italy 213.5.4 The UK 213.5.5 Other European Countries 223.5.6 European OTC Market Forecasts 233.6 Japanese OTC Market 243.6.1 Japanese OTC Market Forecasts 253.7 North American OTC Market 263.7.1 The US 273.7.2 Canada 283.7.3 Latin American Countries 28
    • 3.7.4 North America OTC Market Forecasts 293.8 Trends and Conclusions 304 Market Drivers and Restraints 315 Growing and Aging Populations 325.1 Emerging Consumer 345.2 Consumer Empowerment and Education 35List of FiguresList of Tables are also include.For more DISCOUNT related Reports Plz follow The link:Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations,Regulatory Approvals and Increasing Disease Prevalence Present GrowthOpportunitiesCardiac Assist Device Market to 2017 – Increasing Uptake of Ventricular AssistDevices and Total Artificial Heart to Drive GrowthGeneric Growth Strategies - Manufacturers to Increase Focus on Super Generics andBiosimilars to Drive RevenuesRx-to-OTC Switching Strategies - New Switching Opportunities in WeightManagement and Smoking Cessation, but Encouraging the Uptake of Self-MedicationRemains a ChallengeAntifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylaminesand Echinocandins to Slow Value GrowthSearch More Reports Related to This Category :
    • Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1Biobetters in Key Markets - Opportunities for Biotechnology Companies to SustainInnovation with Low Risk and High Value OfferingsGeneric Growth Strategies - Manufacturers to Increase Focus on Super Generics andBiosimilars to Drive RevenuesRx-to-OTC Switching Strategies - New Switching Opportunities in WeightManagement and Smoking Cessation, but Encouraging the Uptake of Self-MedicationRemains a ChallengeAntifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles,Allylamines and Echinocandins to Slow Value GrowthYou can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com